文献速递乳腺技术与安全US乳腺X线

空芯针活检在原发性乳腺淋巴瘤中的作用

Role of core needle biopsy in primary breast lymphoma.
PubMed 文献 · Radiol Med · 2017-05-16

该单中心回顾性研究报道了2000年1月至2016年12月期间在Careggi佛罗伦萨大学医院经空芯针活检(CNB)组织学诊断的7例原发性乳腺淋巴瘤(PBL),并与细针穿刺细胞学(FNA)比较;CNB是评估PBL的有效方法,尤其对弥漫大B细胞淋巴瘤(DLBCL),正确快速的分类可能改变治疗策略和预后。

要点

  • PBL临床及乳腺X线、超声表现可与癌相似,鉴别细微。
  • CNB是评估PBL的有效方法,尤其对DLBCL。
  • CNB标本可行荧光原位杂交分析以评估染色体易位。

核心结论

  • CNB是评估PBL的有效方法,尤其对DLBCL,正确且快速的分类可能改变治疗策略和预后。

研究设计与样本

  • 单中心回顾性研究,2000年1月至2016年12月于Careggi佛罗伦萨大学医院共10500例CNB中检出7例PBL患者,并与FNA比较。

关键影像表现/征象

  • PBL临床及乳腺X线和超声表现可与癌相似,鉴别细微。

诊断标准与关键数值

  • DLBCL为最常见的PBL,CNB标本可行荧光原位杂交分析以评估染色体易位。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Primary breast lymphoma (PBL) may mimic carcinoma clinically and also mammographic and ecographic distinction is subtle. Despite its rarity, incidence of PBLs has increased over the last four decades and continues to increase for younger women and for some subtypes, and for this reason it is increasingly important to achieve a preoperative pathological diagnosis using core needle biopsy (CNB) or fine-needle aspiration cytology (FNA). The aim of this retrospective study was to report our single-center experience in CNBs performed for histological diagnosis of PBL compared to FNA. From a total of 10,500 CNBs we found seven patients affected by PBL diagnosed at Careggi Florence University Hospital, between January 2000 and December 2016. Diffuse large B cell lymphoma (DLBCL) was the most frequent PBLs and on CNBs specimens was possible do the fluorescent in situ hybridization analysis to evaluate the presence of chromosomal translocation. CNB is an effective method for the assessment of PBLs, especially for DLBCL, in which a correct and fast classification could change the therapeutic approach and the prognosis.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Bicchierai G, Rigacci L, Miele V, et al. Role of core needle biopsy in primary breast lymphoma. Radiol Med. 2017. PMID: 28510806. doi:10.1007/s11547-017-0773-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。